Conning Inc’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,615
Closed -$817K 449
2020
Q1
$817K Sell
4,615
-57
-1% -$10.7K 0.03% 196
2019
Q4
$893K Buy
4,672
+160
+4% +$28.9K 0.03% 218
2019
Q3
$759K Sell
4,512
-318
-7% -$51.8K 0.03% 251
2019
Q2
$809K Sell
4,830
-730
-13% -$101K 0.03% 241
2019
Q1
$814K Sell
5,560
-376
-6% -$54.5K 0.03% 272
2018
Q4
$793K Sell
5,936
-1,143
-16% -$187K 0.03% 264
2018
Q3
$1.35M Sell
7,079
-610
-8% -$112K 0.04% 229
2018
Q2
$1.28M Sell
7,689
-200
-3% -$32.1K 0.04% 252
2018
Q1
$1.33M Buy
7,889
+130
+2% +$21.8K 0.04% 235
2017
Q4
$1.27M Sell
7,759
-854
-10% -$153K 0.04% 251
2017
Q3
$1.76M Sell
8,613
-80
-0.9% -$18.6K 0.06% 208
2017
Q2
$2.11M Sell
8,693
-371
-4% -$87.2K 0.08% 181
2017
Q1
$2.17M Sell
9,064
-985
-10% -$229K 0.08% 172
2016
Q4
$2.11M Sell
10,049
-438
-4% -$90.7K 0.08% 173
2016
Q3
$2.42M Buy
10,487
+100
+1% +$24.4K 0.1% 159
2016
Q2
$2.4M Buy
10,387
+10
+0.1% +$2.31K 0.1% 160
2016
Q1
$2.78M Buy
10,377
+220
+2% +$63K 0.12% 140
2015
Q4
$3.17M Sell
10,157
-330
-3% -$98.2K 0.14% 131
2015
Q3
$2.85M Sell
10,487
-1,000
-9% -$307K 0.13% 134
2015
Q2
$3.49M Buy
11,487
+18
+0.2% +$5.37K 0.14% 124
2015
Q1
$3.41M Buy
11,469
+4,069
+55% +$1.16M 0.15% 108
2014
Q4
$1.91M Sell
7,400
-149
-2% -$37.2K 0.09% 163
2014
Q3
$1.82M Buy
7,549
+2,544
+51% +$569K 0.1% 161
2014
Q2
$1.12M Hold
5,005
0.06% 224
2014
Q1
$1.03M Buy
5,005
+720
+17% +$143K 0.06% 226
2013
Q4
$720K Buy
4,285
+852
+25% +$133K 0.04% 264
2013
Q3
$494K Buy
3,433
+228
+7% +$30.4K 0.04% 291
2013
Q2
$405K Buy
+3,205
New +$363K 0.03% 305

Other funds holding AGN

Conning Inc's AGN Position: Q2 2020 in Review

Conning Inc sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,615 shares — an estimated $817K sold.

Conning Inc first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $3.49M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Conning Inc reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Conning Inc sold 4,615 Allergan plc shares in Q2 2020, an estimated $817K.
  • Conning Inc first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Conning Inc's Allergan plc position peaked at $3.49M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Conning Inc's 13F filing for Q2 2020, filed 7 Aug 2020.